On Labor Day 2025: From Health Care “Revenue Bounty Hunters,” Medical Bills Back into FICO Scores, the Rise of “Cute Debt,” and Tariffs — U.S. Consumers’ Face Eroding Financial Health
On this U.S. Labor Day 2025, the physical and the fiscal, with the mental, converge as I ponder what working Americans are facing….packing kids up for school, sorting out college payments and loans, dealing with rising costs of daily living, and feeling a growing pinch of what President Trump’s tariffs have had in store now that they’re hitting SKUs around the household. This post will cover most days this week as my own workflows will be heavy as clients return to face returns-to-work and updating scenario plans. We start this post with a headline: “Why Hospitals Are Hiring ‘Revenue Bounty
Prescription Drug Pricing in America – a 3-Part Update, From the Over- the-Counter OPill and “Half-Price” Ozempic to Most-Favored-Nation Rx (Part 3)
Welcome to Part 2 of 3 in my consideration of Prescription Drug Pricing in America. You can catch up with yesterday’s Part 1 post here, and Part 2 here. The macro-context for these 3 posts are the forecasts for health care spending for the coming year. Health care cost increases forecasted for 2026 will, in significant part, be driven by prescription drug trend. This graphic from this week’s release of the Business Group on Health’s employer survey on healthcare cost growth to 2026 illustrates a key finding that’s echoed in other similar studies recently released and covered here in Health Populi.
Prescription Drug Pricing in America – a 3-Part Update, From the Over- the-Counter OPill and “Half-Price” Ozempic to Most-Favored-Nation Rx (Part 1)
Health care costs will increase, overall, as much as 10% in 2026, the consensus of several health benefit analysts inform us. And, “workers to bear brunt of health cost increases in 2026,” reads today’s Axios headline on the topic, weaving together several studies from the Business Group on Health, Mercer, and the International Foundation of Employee Benefit Plans. A kay cost-contributor cited in all of these health cost forecasts is the prescription drug line item: specialty drug prices, and specifically the costs of GLP-1 medicines and cancer therapies. One strategy gaining fast-traction on both the
What U.S. Consumers Are Thinking About Tariffs’ Impacts on Health Care: Looking to Ipsos, QCentrix and Goldman Sachs
Most Americans, thinking as health consumers, believe that tariffs could impact peoples’ ability to pay for costly prescription drugs and be priced out of paying for check-ups and medical supplies, based on results from two studies on consumers’ views on tariffs and their health care from Ipsos and Q-Centrix. Ipsos’s consumer survey found that younger consumers, people earning lower incomes, and folks living in the suburbs feel even more stressed about tariffs’ impact on medical care — along with more people identifying as Democrats or Independent voters. With
The Patient as Consumer – Updates from Fidelity on Retiree Health Care Costs ($172,500), Delaying Care, Tariff Impacts on Spending, and Roche Going DTPatient for Rx’s?
As of August 2025, U.S. patients of all demographics and geographies face many uncertainties with respect to their care. Issues such as health plan coverage, prescription drug costs, and access to services, among other challenges, continue to re-shape patients-as-health-consumers seeking transparency, clinical choices, and trust-worthy relationships with touchpoints in their personal health ecosystems. Four just-breaking stories across the health/care ecosystem illustrate several of these uncertainties and forces in U.S. health care — some adding friction and angst in a patient’s life, others perhaps providing some relief for certain health consumers. These news items address health care costs in retirement, the
We Go Further Together: Calling for Collaborations, An Actionable Context for AHIP 2025
There are many ways to measure the dysfunction of health care in the U.S.: we can point to relatively poor incomes relative to the rest of the developed world, given how much money is allocated to health care in America. The maternal mortality rate in the U.S. is unconscionably high, akin to some middle- and lower-income nations in the world. And medical debt is a uniquely American form of financial toxicity compared with other OECD nations where the concept is, well, foreign. Even with these many failures, though, it’s important to put U.S. health care in a larger context: the
A Toyota RAV4 Hybrid, a Playground Set, or Healthcare for a Family of 4: What $35,119 Can Buy in 2025 According to Milliman
If you went shopping for something that cost $35,119 in 2025, which would you most value? A new 2025 Toyota RAV4 Hybrid with some extras on board? A Canyon BYO playground set for your yard, school, or social-athletic club? Or, Healthcare coverage for a family of 4 in the form of a PPO? Welcome to this year’s 20th anniversary edition of the Milliman Medical Index (MMI), which I’ve looked forward to reviewing for most of its two-decade history. [You can read my annual takes on the MMI here in Health Populi by searching “MMI” and the year of publication in
Health, Wealth, and How Business Can Support Consumers in an Era of “Uncertainty on Steroids”
Facing uncertainties across everyday life flows, U.S. consumers look to economic and health security — and welcome businesses to support these, we learn in an analysis from The Conference Board. The Conference Board (TCB) polled 3,000 U.S. consumers gauging their perspectives on uncertainties emerging out of the new Trump administration’s policy changes introduced in the first quarter of 2025. The chart details people’s financial/fiscal responses in blue, and the health (mental, social, and physical aspects) in yellow: Consumers’ fiscal strategies for coping with uncertainty are to seek out more affordable brands and retailers, adjusting
If Food Is Medicine, Some Might Feel It’s a Luxury Good Like a Specialty Drug
Most people in the U.S. say it’s harder to eat healthy given the cost of “healthy food,” we learn in the report on Americans on Healthy Food and Eating from the Pew Research Center, published 7 May 2025. With a view that healthy food is “too expensive,” it may feel like aspiring for it feels like luxury-good shopping, or being a patient prescribed a specialty (high-cost) drug. The Pew team polled 5,123 U.S. adults’ perspectives on eating, fielded between 24 February and 2 March 2025. This report is timely as Secretary of Health and
How Consumers’ Economic Sentiments Are Shaping Peoples’ Financial and Emotional Well-Being (Spoiler: Not So Good): Learning from CivicScience
When it comes to health, the words “fiscal” and “physical” are morphing as peoples’ economic feelings (the “fiscal”) are shaping physical and emotional health, we find in U.S. consumer data presented by John Dick, Founder and CEO of CivicScience. The Consumer Technology Association convened a special session with John, who painted a portrait of the U.S. consumer at a point in time — late April 2025 — reminding us more than once during the hourlong session that, “Everything is constantly changing.” One certainty that we can be sure of, in the dismal-scientist way
Are We Liberated Yet? Tariffs Can Impact Financial Health (Riffing on MoneyLion’s Health Is Wealth Report)
Americans’ financial health was already stressing consumers out leading up to Liberation Day, April 2nd, when President Trump announced tariffs on dozens of countries with whom the U.S. buys and sells goods. A new report from MoneyLion and Mastercard called Health is Wealth is well-timed for today’s Health Populi blog. The study was fielded by The Harris Poll online among 2,092 U.S. adults 18 and older between February 28 and March 4, 2025, so it was completed a month before the tariffs came to hit peoples’ 401(k) savings and employers’ company stock market caps.
I'm once again pretty gobsmackingly happy to have been named a judge for the 2026 CES Innovation Awards, focusing on digital health, longevity, and fitness. Preceding every year's global conference, CES receives hundreds of applications from innovators around the world building tech-based solutions to big challenges. So glad to be part of this annual initiative to see what global health-tech pioneers are cooking up to address and scale the health and well-being of fellow health citizens, globally.
You can see the results of the Digital Health Awardees here on the #CES2026 website.
Stay tuned to Health Populi in early January as I'll be attending Media Days and meeting with innovators in digital health, longevity, and the home-for-health during CES 2026 in Las Vegas. I'll be at the conference for an entire week meeting with clients and exhibitors at the biggest-meeting-of-the-year on consumer-facing technology. I'll be reporting daily from Vegas here in the blog, sharing with you insights about the latest breakthroughs, products, and services that enable people to manage health, well-being, and medical issues in their own hands and homes.
Jane collaborated on Robin Strongin's Health Dame webcast to discuss Halle Tecco's new book, Massively Better Healthcare, due out in early 2026. We brainstormed with Maven Founder Kate Ryder and the company's Chief Medical Officer Dr. Neel Shah about the state of U.S. healthcare and solutions not just to tweak at the margins but to "massively" improve health care delivery, financing, outcomes, and equity in America. It was a delightful, enlightening conversation -- I hope you'll check it out.